Herbalife Ltd (HLF)
(Delayed Data from NYSE)
$8.51 USD
+0.14 (1.67%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $8.50 -0.01 (-0.12%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.51 USD
+0.14 (1.67%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $8.50 -0.01 (-0.12%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth C Momentum A VGM
Zacks News
Earnings Preview: Herbalife LTD. (HLF) Q3 Earnings Expected to Decline
by Zacks Equity Research
Herbalife LTD. (HLF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Walgreens Boots Alliance (WBA) Beats Q4 Earnings Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of 2.56% and 0.13%, respectively, for the quarter ended August 2022. Do the numbers hold clues to what lies ahead for the stock?
Herbalife LTD. (HLF) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Herbalife LTD. (HLF) delivered earnings and revenue surprises of 52.38% and 7.54%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate CVS Health (CVS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Herbalife LTD. (HLF) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Herbalife LTD. (HLF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Herbalife LTD. (HLF) Soars 15.2%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Herbalife LTD. (HLF) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Herbalife LTD. (HLF) Q1 Earnings Beat Estimates
by Zacks Equity Research
Herbalife LTD. (HLF) delivered earnings and revenue surprises of 13.79% and 2.95%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Rite Aid (RAD) Stock Jumps 7.4%: Will It Continue to Soar?
by Zacks Equity Research
Rite Aid (RAD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Herbalife LTD. (HLF) Q4 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Herbalife LTD. (HLF) delivered earnings and revenue surprises of -3.39% and 3.74%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
CVS Health (CVS) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 2.06% and 0.79%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Is Herbalife (HLF) a Worthy Stock for Value Investors?
by Zacks Equity Research
Is Herbalife (HLF) a great pick from the value investor's perspective right now? Read on to know more.
Herbalife LTD. (HLF) Q3 Earnings Top Estimates
by Zacks Equity Research
Herbalife LTD. (HLF) delivered earnings and revenue surprises of 15.24% and -1.29%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Herbalife LTD. (HLF) Q3 Earnings Expected to Decline
by Zacks Equity Research
Herbalife LTD. (HLF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for October 5th
by Zacks Equity Research
BABA, BBBY, DAN, AVO, and HLF have been added to the Zacks Rank #5 (Strong Sell) List on October 5, 2021.
Company News for Sep 15, 2021
by Zacks Equity Research
Companies in The News Are: FCEL,ORCL,AVO,HLF
Here's Why Herbalife LTD. (HLF) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Herbalife LTD. (HLF) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Herbalife LTD. (HLF) delivered earnings and revenue surprises of 20.63% and 0.34%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Herbalife LTD. (HLF) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Herbalife LTD. (HLF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Industry Outlook Highlights: CVS Health, Walgreen Boots, Herbalife and Amazon
by Zacks Equity Research
Zacks Industry Outlook Highlights: CVS Health, Walgreen Boots, Herbalife and Amazon
Bear of the Day: Rite Aid (RAD)
by David Bartosiak
The competition is fierce and earnings are moving in the wrong direction
3 Retail Pharmacy and Drugstore Stocks to Watch Amid Pandemic Woes
by Urmimala Biswas
The Zacks Retail Pharmacy and Drugstore industry is gaining from growing demand for digital healthcare support. Industry players CVS, WBA and HLF are set to gain the most. However, Amazon's entry threat disrupts this uptrend.
Amazon's Physical Pharmacy Not a Grave Threat: 3 Stocks to Buy
by Urmimala Biswas
Investors should not lose optimism and continue to discover the enormous business opportunities this retail pharmacy- drug store industry holds. Here are three stocks, WMT, UNH, HLF, which you can grab now.
Surging Earnings Estimates Signal Upside for Herbalife LTD. (HLF) Stock
by Zacks Equity Research
Herbalife LTD. (HLF) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
4 Sector ETFs & Stocks to Shine Despite Soft April Retail Sales
by Sanghamitra Saha
Retail sales in the United States were unchanged in April 2021, falling shy of market expectations of a 1% increase.
4 Must-Buy Efficient Stocks to Enrich Your Portfolio
by Tirthankar Chakraborty
Crocs (CROX), MEDIFAST (MED), Golden Entertainment (GDEN) and Herbalife (HLF) are the top companies that at present have favorable efficiency level and thus are expected to provide stellar returns.